Skip to Main Content

Paper Details

Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis.
Neurooncol Adv
31
2020
GBM, MGMT, MGMT promoter, TMZ, glioblastoma, patients, temozolomide
Author NameAffiliation
Joshua D PalmerThe Ohio State University Wexner Medical Center
Shirley OngThe Ohio State University Wexner Medical Center
Mohammad Hassan MuradMayo Clinic
Mohammad Hassan MuradMayo Clinic
Vinay K PuduvalliThe Ohio State University Wexner Medical Center
  • 1 - 5

Datasets

Release 1.2